[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.14476/jomp.2018.43.4.99

Sjögren's Syndrome: an Update on Diagnostic, Clinical, and Basic Aspects for Oral Medicine Specialists

Lee, Kyung-Eun (Department of Oral Medicine, School of Dentistry, Institute of Oral Bioscience, Chonbuk National University)

Publication Information

Journal of Oral Medicine and Pain / v.43, no.4, 2018 , pp. 99-111 More about this Journal

Abstract

$Sj{\ddot{o}}gren^{\prime}s$ syndrome (SjS) is a common autoimmune disorder characterized by lymphocytic infiltration in the salivary and lacrimal glands, resulting in severe dry mouth or eyes. As a result, most of SjS patients suffer from oral dryness and can visit the department of oral medicine with or without diagnosis of SjS. Therefore, oral medicine specialists should know clues, which may indicate the diagnosis of SjS from the clinical and laboratory investigations. By the recent SjS criteria, SjS can be diagnosed by focus score, ocular staining, Schirmer's test, unstimulated whole saliva flow rate, and anti-SSA/Ro antibodies. The aim of this article is to review the diagnostic criteria, clinical investigation, and basic aspect related to SjS and to make oral medicine specialists play an important role in the detection of emerging SjS.

Keywords

Biopsy; Oral medicine; $Sj{\ddot{o}}gren^{\prime}s$ syndrome; SSA antibodies; Staining and Labeling; Xerostomia;

Citations & Related Records

Reference

1	Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum 1974;17:421-429. DOI
2	Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjogren's syndrome. J Clin Invest 1975;55:1067-1073. DOI
3	Alspaugh M, Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjogren's syndrome: an interlaboratory collaboration. Arthritis Rheum 1979;22:796-798. DOI
4	Ben-Chetrit E. Target antigens of the SSA/Ro and SSB/La system. Am J Reprod Immunol 1992;28:256-258. DOI
5	Ben-Chetrit E. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies. Br J Rheumatol 1993;32:396-402. DOI
6	Shen L, Suresh L. Autoantibodies, detection methods and panels for diagnosis of Sjogren's syndrome. Clin Immunol 2017;182:24-29. DOI
7	Quartuccio L, Baldini C, Bartoloni E, et al. Anti-SSA/SSB-negative Sjogren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev 2015;14:1019-1022. DOI
8	Baer AN, McAdams DeMarco M, Shiboski SC, et al. The SSBpositive/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome. Ann Rheum Dis 2015;74:1557-1561. DOI
9	Fauchais AL, Martel C, Gondran G, et al. Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 2010;9:595-599. DOI
10	Baldini C, Zabotti A, Filipovic N, et al. Imaging in primary Sjogren's syndrome: the 'obsolete and the new'. Clin Exp Rheumatol 2018;36 Suppl 112:215-221.
11	Golder W, Stiller M. Distribution pattern of Sjogren's syndrome: a sialographical study. Z Rheumatol 2014;73:928-933. DOI
12	Song GG, Lee YH. Diagnostic accuracies of sialography and salivary ultrasonography in Sjogren's syndrome patients: a metaanalysis. Clin Exp Rheumatol 2014;32:516-522.
13	Angusti T, Pilati E, Parente A, et al. Semi-quantitative analysis of salivary gland scintigraphy in Sjogren's syndrome diagnosis: a first-line tool. Clin Oral Investig 2017;21:2389-2395. DOI
14	Aksoy T, Kiratli PO, Erbas B. Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjogren's syndrome. Clin Rheumatol 2012;31:1365-1370. DOI
15	Nadal M, Levy M, Bakhsh A, et al. Salivary scintigraphy for Sjogren's syndrome in patients with xerostomia: a retrospective study. Oral Dis 2018;24:552-560. DOI
16	Ogura I, Sasaki Y, Oda T, Sue M, Hayama K. Magnetic resonance sialography and salivary gland scintigraphy of parotid glands in Sjogren's syndrome. Chin J Dent Res 2018;21:63-68.
17	Kojima I, Sakamoto M, Iikubo M, et al. Diagnostic performance of MR imaging of three major salivary glands for Sjogren's syndrome. Oral Dis 2017;23:84-90. DOI
18	Carr AJ, Ng WF, Figueiredo F, Macleod RI, Greenwood M, Staines K. Sjogren's syndrome - an update for dental practitioners. Br Dent J 2012;213:353-357. DOI
19	Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren's syndrome: a place in the diagnostic criteria? Rheum Dis Clin North Am 2016;42:501-517. DOI
20	Martire MV, Santiago ML, Cazenave T, Gutierrez M. Latest advances in ultrasound assessment of salivary glands in Sjogren syndrome. J Clin Rheumatol 2018;24:218-223. DOI
21	Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004;164:1275-1284. DOI
22	Soto-Rojas AE, Kraus A. The oral side of Sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res 2002;33:95-106. DOI
23	Generali E, Costanzo A, Mainetti C, Selmi C. Cutaneous and mucosal manifestations of Sjogren's syndrome. Clin Rev Allergy Immunol 2017;53:357-370. DOI
24	Blochowiak K, Olewicz-Gawlik A, Polanska A, et al. Oral mucosal manifestations in primary and secondary Sjogren syndrome and dry mouth syndrome. Postepy Dermatol Alergol 2016;33:23-27.
25	Napenas JJ, Rouleau TS. Oral complications of Sjogren's syndrome. Oral Maxillofac Surg Clin North Am 2014;26:55-62. DOI
26	Pedersen AM, Reibel J, Nordgarden H, Bergem HO, Jensen JL, Nauntofte B. Primary Sjogren's syndrome: salivary gland function and clinical oral findings. Oral Dis 1999;5:128-138.
27	Gonzalez S, Sung H, Sepulveda D, Gonzalez M, Molina C. Oral manifestations and their treatment in Sjogren's syndrome. Oral Dis 2014;20:153-161. DOI
28	Nishishinya MB, Pereda CA, Munoz-Fernandez S, et al. Identification of lymphoma predictors in patients with primary Sjogren's syndrome: a systematic literature review and meta-analysis. Rheumatol Int 2015;35:17-26. DOI
29	Holdgate N, St Clair EW. Recent advances in primary Sjogren's syndrome. F1000Res 2016;5. pii: F1000 Faculty Rev-1412.
30	Ramos-Casals M, Brito-Zeron P, Seror R, et al; EULAR Sjogren Syndrome Task Force. Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 2015;54:2230-2238. DOI
31	Ramos-Casals M, Anaya JM, Garcia-Carrasco M, et al. Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004;83:96-106. DOI
32	Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun 2012;39:27-33. DOI
33	Meijer JM, Meiners PM, Huddleston Slater JJ, et al. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford) 2009;48:1077-1082. DOI
34	Fox RI. Sjogren's syndrome. Lancet 2005;366:321-331. DOI
35	Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dorner T. The diagnosis and treatment of Sjogren's syndrome. Dtsch Arztebl Int 2017;114:354-361.
36	Bayetto K, Logan RM. Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010;55 Suppl 1:39-47. DOI
37	Brito-Zeron P, Theander E, Baldini C, et al; Eular Sjogren Syndrome Task Force. Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 2016;12:137-156. DOI
38	Ramos-Casals M, Tzioufas AG, Font J. Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-354.
39	Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012;344:e3821. DOI
40	Ko MY, Heo JY, Ok SM, Kin KH, Jeong SH, Ahn YW. The analysis and study of first visit outpatients in oral medicine. J Oral Med Pain 2013;38:137-142. DOI
41	Scully C, Felix DH. Oral medicine -- update for the dental practitioner: dry mouth and disorders of salivation. Br Dent J 2005;199:423-427. DOI
42	Billings M, Amin Hadavand M, Alevizos I. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjogren's syndrome: findings from the NIH cohort. Oral Dis 2018;24:184-190. DOI
43	Rasmussen A, Ice JA, Li H, et al. Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 2014;73:31-38.
44	Shiboski SC, Shiboski CH, Criswell L, et al; Sjogren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475-487. DOI
45	Vitali C, Bombardieri S, Jonsson R, et al; European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558. DOI
46	van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10-14. DOI
47	Franceschini F, Cavazzana I, Andreoli L, Tincani A. The 2016 classification criteria for primary Sjogren's syndrome: what's new? BMC Med 2017;15:69. DOI
48	Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol 2010;149:405-415. DOI
49	Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35-45. DOI
50	Daniels TE, Cox D, Shiboski CH, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren's syndrome among 1,726 registry participants. Arthritis Rheum 2011;63:2021-2030. DOI
51	Sjogren's International Collaborative Clinical Alliance Research Groups (SICCA). SICCA questionnaires, forms & protocols [Internet]. San Francisco: SICCA; c2005. [cited 2018 Nov 15] Available from: https://sicca-online.ucsf.edu/documents/LSG_bx_Grading_SOP.pdf.
52	Navazesh M, Kumar SK; University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008;139 Suppl:35S-40S. DOI
53	Jonsson R, Brokstad KA, Jonsson MV, Delaleu N, Skarstein K. Current concepts on Sjogren's syndrome - classification criteria and biomarkers. Eur J Oral Sci 2018;126 Suppl 1:37-48. DOI
54	Gomes Pde S, Juodzbalys G, Fernandes MH, Guobis Z. Diagnostic approaches to Sjogren's syndrome: a literature review and own clinical experience. J Oral Maxillofac Res 2012;3:e3.
55	Rischmueller M, Tieu J, Lester S. Primary Sjogren's syndrome. Best Pract Res Clin Rheumatol 2016;30:189-220.
56	Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 1969;102:117-122.